Every “optimal range” you have been shown was published by someone selling something.

There is unusually little scientific disagreement here: apoB is one of the best-validated markers in the registry. The disagreement is about who should act on it and at what threshold. A laboratory reports a population-derived cutoff around 90 mg/dL. A preventive clinic markets 80, then 60. None of those numbers mean anything without your absolute risk, your age, and your family history, and a number sold as a universal target is a marketing decision rather than a clinical one.

The dispute is not about whether Lp(a) matters; it does. It is about whether a consumer panel should measure it repeatedly. Because the value is genetically fixed, one lifetime measurement is sufficient for nearly everyone. Panels that re-run it every six months are billing you annually for a number that will not move. Note also that nmol/L and mg/dL results are not reliably interconvertible, so comparing across platforms that report different units is unsound.

Most LDL-C values on consumer panels are estimated using an equation, not directly assayed, and the equations become unreliable when triglycerides are high or LDL is very low. This matters for a specific reason: when a platform advertises a biomarker count, calculated values like this one are frequently counted alongside directly measured ones. If your LDL-C looks implausible next to your apoB, the equation is the likely explanation.

This is the registry's cleanest example of the difference between a marker and a lever. HDL-C predicts risk; raising it does not reduce risk. Any product that sells you an intervention to raise HDL-C is selling a change in a number rather than a change in your outcome. The word 'optimal' does a great deal of concealed work here.

Almost all the disagreement here is about measurement conditions rather than biology. Triglycerides swing widely with recent food, alcohol, and illness. A platform that draws blood without confirming a genuine fast, then flags your result against a tight 'optimal' cutoff, is generating findings from noise. Ask what fasting state your draw assumed before you act on the number.

The diagnostic thresholds are solid. The 'optimal' targets below them are considerably shakier, because red blood cell turnover confounds the measurement precisely in the range where consumer platforms make their claims. Someone with mild iron deficiency can post an HbA1c several tenths higher than their actual glucose exposure warrants. If your HbA1c and fasting glucose tell different stories, check your iron studies before you change your diet.